Currently out of the existing stock ratings of Ryan Blicker, 9 are a BUY (100%).

Ryan Blicker

Work Performance Price Targets & Ratings Chart

Analyst Ryan Blicker, carries an average stock price target met ratio of 100% that have a potential upside of 11.68% achieved within 72 days. Previously, Ryan Blicker worked at TD COWEN.

Ryan Blicker’s has documented 20 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on DXCM, DexCom at 07-Jul-2020.

Wall Street Analyst Ryan Blicker

Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for DXCM (DEXCOM) at 4/1/2020. The price target of $75 was fulfilled within 15 days with a profit of $11.3 (17.74%) receiving and performance score of 11.83.

Average potential price target upside

DXCM DexCom TNDM Tandem Diabetes Care PODD Insulet

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Aug-2017

$84

$21.78 (35.00%)

$75

30 days ago
(11-Mar-2026)

18/30 (60%)

$17.69 (26.68%)

113

Buy Since 03-Feb-2022

$85

$22.78 (36.61%)

$85

1 months 1 days ago
(09-Mar-2026)

5/14 (35.71%)

$16.26 (23.65%)

167

Buy Since 29-Jul-2022

$85

$18.05 (26.96%)

$93

1 months 24 days ago
(17-Feb-2026)

10/16 (62.5%)

$14.98 (21.39%)

91

Buy Since 16-Jun-2025

$80

$17.78 (28.58%)

1 months 24 days ago
(17-Feb-2026)

0/4 (0%)

$9.57 (13.59%)

Sell Since 13-Feb-2026

$72

$9.78 (15.72%)

$71

1 months 28 days ago
(13-Feb-2026)

7/11 (63.64%)

$1.98 (2.83%)

46

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ryan Blicker?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?